期刊文献+

K562冻融抗原负载的树突状细胞诱导抗慢性粒细胞白血病的免疫效应 被引量:2

An in vitro dendritic cells-induced T lymphocytes cytotoxicity study activated by thaw frozen K562 lysates antigen in chronic myeloid leukemia
原文传递
导出
摘要 目的研究K562冻融抗原负载的健康供者来源的树突状细胞(DC)诱导细胞毒性T淋巴细胞(CTL)体外杀伤慢性粒细胞白血病(CML)细胞的毒性效应。方法利用健康供者外周血单个核细胞诱导分化为DC,采用反复冻融法从K562中提取的可溶性相关抗原负载DC;流式细胞学检测负载抗原前后DC表面分子表达的变化;ELISA法检测DC上清中IL-12和IFNγ的含量;混合淋巴细胞反应(MLR)测定DC体外刺激T细胞增殖的能力;乳酸脱氢酶法检测K562冻融抗原负载DC诱导的抗原特异性CTL对CML细胞的杀伤作用。结果与未经抗原负载的DC相比,经K562抗原负载的DC表面分子表达明显上调,CD1a(27·40±5·00)%、(15·40±2·34)%,CD80(61·35±5·35)%、(42·00±2·77)%,CD83(93·30±3·48)%、(25·15±4·02)%,CD86(85·25±4·39)%、(37·25±3·20)%,CD40(89·80±7·18)%、(35·95±4·06)%,HLA-DR(49·50±5·45)%、(17·15±3·61)%,DC分泌IL-12和诱导T细胞分泌IFNγ的能力增加(P<0·05),具有很强的刺激T细胞增殖能力,且刺激强度在24h最强,48h降低,冻融抗原负载DC后激活的CTL在体外对K562的杀伤率为77·35%,显著高于未经抗原负载的DC(P=0·001)。结论经K562细胞冻融抗原负载DC激活的CTL在体外具有更强的增殖能力和杀伤CML细胞的作用。 Objective To investigate the anti-chronic myeloid leukemia(CML) effect of cytotoxicity T lymphocytes(CTL) activated by dendritic cells (DC) pulsed with freeze thaw K562 lysates antigan. Methods DC were achieved by healthy donors peripheral blood monocytes which were induced by granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-4. On the sixth day, these cells were collected. One part of them was usecl to prove that they were DC from morphology and phenotypes. The other part was pulsed with K562 lysates and the lysate-loaded DC were compared with immature DC from phenotypes . The expression of IL-12 and IFNγ in supernatant, the mixed lymphocytes reaction and the specific cytotoxicity against leukemia cells were tested. Results Freeze thaw K562 lysate up-regulated the expression of various differentiation antigens of DC, such as CD1a (27.40± 5.00) % vs ( 15.40 ± 2.34) %, CD80(61.35 ±5.35)% vs (42.00 ±2.77)%,CD83 (93.30 ±3.48)% vs (25.15 ±4.02)%,CD86 (85.25±4.39)% vs (37.25 ±3.20)%,CD40(89.80 ±7. 18)% vs (35.95 ±4.06)% and HLA-DR (49.50 ± 5.45) % vs ( 17.15 ± 3.61 ) %. Simultaneously, the expression of IL-12 rose after DC were loaded with tumor lysates after 24 hours ( P 〈 0. 05 ). The T cells from healthy donors and CML patients, proliferated by antigen loaded DC, could induce IFNγ increase(P 〈0. 01 ). The proliferation of T cells had distinct relation with the time of antigen loaded with DC. These T cells had specific cytotoxicity against K562 and HLA partial matching CML cells. Conclusions DC pulsed with K562 lysates can stimulate T cells, and can keep high immunocompetence with specific cytotoxicity against K562.
出处 《中华内科杂志》 CAS CSCD 北大核心 2006年第12期1013-1016,共4页 Chinese Journal of Internal Medicine
基金 湖北省自然科学基金资助项目(2001ABB159)
关键词 白血病 髓样 慢性 K562细胞 树突细胞 Leukemia, myeloid, chronic K562 cells Dendritic cells
  • 相关文献

参考文献11

  • 1Banchereau J,Briere F,Caux C,et al.Immunobiology of dendritic cells.Annu Rev Immunol,2000,18:767-811.
  • 2Takahashi T,Tanaka Y,Nieda M,et al.Dendritic cell vaccination for patients with chronic myelogenous leukemia.Leuk Res,2003,27:795-802.
  • 3Cathcart K,Pinilla-Ibarz J,Korontsvit T,et al.A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.Blood,2004,103:1037-1042.
  • 4Choudhury A,Gajewski JL,Liang JC,et al.Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.Blood,1997,89:1133-1142.
  • 5Eisendle K,Lang A,Eibl B,et al.Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.Br J Haematol,2003,120:63-73.
  • 6Eisendle K,Wolf D,Gastl G,et al.Dendritic cells from patients with chronic myeloid leukemia:functional and phenotypic features.Leuk Lymphoma,2005,46:663-670.
  • 7Nieda M,Nicol A,Kikuchi A,et al.Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemia cells from patients with chronic myeloid leukemia.Blood,1998,91:977-983.
  • 8Vegh Z,Mazumder A.Generation of tumor cell lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response.Cancer Immunol Immunother,2003,52:67-79.
  • 9Langenkamp A,Messi M,Lanzavecchia A,et al.Kinetics of dendritic cell activation:impact on priming of TH1,TH2 and nonpolarized T cells.Nat Immunol,2000,1:311-316.
  • 10Battle TE,Wierda WG,Rassenti LZ,et al.In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.Clin Cancer Res,2003,9:2166-2172.

同被引文献21

  • 1王云甫,孙圣刚,何国厚,陈吉相,杨敬宁,李罗清,曹学兵,吴雄文.体外诱导扩增大鼠树突状细胞及其特性鉴定[J].细胞与分子免疫学杂志,2005,21(1):76-78. 被引量:14
  • 2倪秀雄,陈玄,张文豪.沙培林诱导脐血树突状细胞的成熟[J].福建医科大学学报,2006,40(4):357-360. 被引量:5
  • 3Yu J S, Liu G, Ying H, et al. Vaccination with tumor lysatepulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma [J]. Cancer Res, 2004, 64 (14):4973-4979.
  • 4Inaba K,Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor[J]. J Exp Med, 1992,176(6) : 1693-1702.
  • 5Elkord E, Williams P E, Kynaston H, et al. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells[J]. Immunology, 2005, 114 (2): 204-212.
  • 6Somersan S, LarssonM,Fonteneau J F,et al. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells[J]. J Immunol,2001, 167(9):4844-4852.
  • 7Nakahara S,Tsunoda T, Baba T, et al. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide[J]. Cancer Res J T - Cancer research, 2003,63 (14,) : 4112-4118.
  • 8Ogihara T, Iinuma H, Okinaga K. Usefulness of immunomodulators for maturation of dendritic cells[J]. Int J Oncol, 2004,25(2) :453-459.
  • 9Okamoto M,Furuiehi S,Nishioka Y,et al. Expression of toll- like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation[J]. Cancer Res, 2004,64 (15) : 5461-5470.
  • 10Kanzaki N,Terashima M, Kashimura S,et al. Understanding the response of dendritic cells to activation by streptococcal preparation OK-432 [J]. Anticancer Res JT - Anticancer research, 2005,25 (6B): 4231-4238.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部